fiveonefour | $17,000,000 | (Sep 5, 2025)
Sesh Products | $40,000,000 | (Sep 5, 2025)
Pointsville | Undisclosed Amount | (Sep 5, 2025)
Certified by Founder
Lodge
Moonwalk Biosciences
start up
United States
- South San Francisco, California
- 08/01/2024
- Series A
- $57,000,000
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.
- Industry Biotechnology Research
- Website https://moonwalk.bio/
- LinkedIn https://www.linkedin.com/company/moonwalk-biosciences/about/
Augment | $85,000,000 | (Sep 5, 2025)
Plural(US) | $7,000,000 | (Sep 5, 2025)
Hello Patient | $22,500,000 | (Sep 5, 2025)
Euclid Power | $20,000,000 | (Sep 5, 2025)
Lead | $70,000,000 | (Sep 5, 2025)
Pave Finance | $14,000,000 | (Sep 5, 2025)
throxy (yc x25) | $6,200,000 | (Sep 5, 2025)
Human Behavior (YC X25) | $5,000,000 | (Sep 5, 2025)
FlexifyMe | $2,400,000 | (Sep 5, 2025)